Contraception in perimenopausal women
ESC Congress Library. Magalhães M. 05/28/14; 50495; A-079
Dr. Miguel Magalhães
Dr. Miguel Magalhães
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Introduction: Contraceptive choice for women aged over 40 years may be influenced by many factors: frequency of intercourse, natural decline in fertility, sexual problems, the wish for noncontraceptive benefits, menstrual dysfunction and concurrent medical conditions. Perimenopause is a transition phase in women’s reproductive life. Usually it’s determined retrospectively after a woman has experienced 12 months of amenorrhea without any other obvious pathological or physiological cause. Oral estrogen-progestin contraceptives are considered to be safe in nonsmokers up to the age of menopause.
Objectives: Access the most effective and appropriate contraceptive methods in perimenopausal women.
Methods: A literature review in Pubmed database, of articles in English and Portuguese, published since 2003, using the MeSH terms \"\"Contraception\"\" and “Perimenopause”.
Results: Estrogen-progestin contraceptives have important non-contraceptive benefits, including improved menstrual irregularities, decreased vasomotor symptoms and beneficial effect on bone mineral density. Progestin contraceptives are very effective in perimenopausal women and can be used in medical conditions that contraindicate estrogen use. Either copper intrauterine devices or the levonorgestrel-releasing intrauterine system are safe and suitable for this age group. Levonorgestrel-releasing intrauterine system presents local benefits in fibroids and endometrial pathology, which are more frequent in perimenopausal women.
Conclusions: When counseling the perimenopausal women, the risks of unintended conception and pregnancy should be weighed against the risks, advantages, and disadvantages associated with a particular contraceptive. In the absence of contraindications, estrogen-progestin contraceptives can be used up to 50 years old in healthy non-smoking women. Around this age, most women should consider suspending estrogen contraceptive and starting one with progestin only, a copper IUD, a levonorgestrel-releasing intrauterine system or a barrier method.
Introduction: Contraceptive choice for women aged over 40 years may be influenced by many factors: frequency of intercourse, natural decline in fertility, sexual problems, the wish for noncontraceptive benefits, menstrual dysfunction and concurrent medical conditions. Perimenopause is a transition phase in women’s reproductive life. Usually it’s determined retrospectively after a woman has experienced 12 months of amenorrhea without any other obvious pathological or physiological cause. Oral estrogen-progestin contraceptives are considered to be safe in nonsmokers up to the age of menopause.
Objectives: Access the most effective and appropriate contraceptive methods in perimenopausal women.
Methods: A literature review in Pubmed database, of articles in English and Portuguese, published since 2003, using the MeSH terms \"\"Contraception\"\" and “Perimenopause”.
Results: Estrogen-progestin contraceptives have important non-contraceptive benefits, including improved menstrual irregularities, decreased vasomotor symptoms and beneficial effect on bone mineral density. Progestin contraceptives are very effective in perimenopausal women and can be used in medical conditions that contraindicate estrogen use. Either copper intrauterine devices or the levonorgestrel-releasing intrauterine system are safe and suitable for this age group. Levonorgestrel-releasing intrauterine system presents local benefits in fibroids and endometrial pathology, which are more frequent in perimenopausal women.
Conclusions: When counseling the perimenopausal women, the risks of unintended conception and pregnancy should be weighed against the risks, advantages, and disadvantages associated with a particular contraceptive. In the absence of contraindications, estrogen-progestin contraceptives can be used up to 50 years old in healthy non-smoking women. Around this age, most women should consider suspending estrogen contraceptive and starting one with progestin only, a copper IUD, a levonorgestrel-releasing intrauterine system or a barrier method.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings